Content about Goldman Sachs

March 3, 2014

Pfizer is recruiting for a 1,200-patient actual use study to measure whether or not patients can appropriately self-select treating high cholesterol with the statin Lipitor, the Wall Street Journal reported on Sunday.

NEW YORK — Pfizer is recruiting for a 1,200-patient actual use study to measure whether or not patients can appropriately self-select treating high cholesterol with the statin Lipitor, the Wall Street Journal reported on Sunday. 

The trial is recruiting patients through more than 35 pharmacies and is expected to be completed by year-end.  

November 14, 2013

Dollar General Corporation on Wednesday announced the resignations of Raj Agrawal and Adrian Jones as members of its board of directors, effective Dec. 5, 2013.

GOODLETTSVILLE, Tenn. — Dollar General Corporation on Wednesday announced the resignations of Raj Agrawal and Adrian Jones as members of its board of directors, effective Dec. 5, 2013. Agrawal, a member of KKR, and Jones, a managing director at Goldman Sachs, have served as directors of Dollar General since 2007.

October 23, 2013

All or part of Safeway may be a target for a possible buyout, according to a Reuters report published Wednesday morning citing people familiar with the matter.

NEW YORK — All or part of Safeway soon may be a target for a possible buyout, according to a Reuters report published Wednesday morning citing people familiar with the matter. 

According to the report, several buyout firms, including Cerberus Capital Management, are exploring a deal for the supermarket chain currently valued at $8 billion. 

July 18, 2013

More than one-third of U.S. consumers say they're likely to spend more during the back-to-school season this year, according to a study.

NEW YORK — More than one-third of U.S. consumers say they're likely to spend more during the back-to-school season this year, according to a study.

April 8, 2013

Blackhawk Network Holdings announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share.

PLEASANTON, Calif. — Blackhawk Network Holdings on Monday announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share. The IPO will consist solely of shares to be offered by existing stockholders, including Safeway, and could raise as much as $220 million. 

February 11, 2013

Mylan has appointed its president and a former partner at Goldman Sachs to its board of directors, the generic drug maker said.

PITTSBURGH — Mylan has appointed its president and a former Goldman Sachs & Co. partner to its board, the generic drug maker said Monday.

Mylan announced the appointment of president Rajiv Malik and former Goldman Sachs partner Melina Higgins to its board.

January 4, 2013

According to a Bloomberg report, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion.

NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

Other companies who have been invited to bid include Merck and Pfizer. 

December 21, 2012

Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.

PARSIPPANY, N.J. — Watson Pharmaceuticals will present at two conferences sponsored by financial banks, the company said.

Watson said that president and CEO Paul Bisaro would provide an overview and update of the company's business at the 2013 Goldman Sachs "Healthcare CEOs Unscripted: A View from the Top" conference, scheduled for Jan. 3, 2013, at the Goldman Sachs Conference Center in New York.

Six days later, on Jan. 9, Bisaro will present at the annual J.P. Morgan Healthcare Conference, at the Westin St. Francis Hotel in San Francisco.

September 18, 2012

Valeant Pharmaceuticals CFO Howard Schiller has been appointed to the drug maker's board of directors.

MONTREAL — Valeant Pharmaceuticals CFO Howard Schiller has been appointed to the drug maker's board of directors.

Schiller joined Valeant as EVP and CFO in December 2011, following a 24-year career at Goldman Sachs. Schiller also serves on the New York board of Teach for America and on the board of the Cancer Research Institute. In addition, he also is on the business advisory council of the University of Chicago Law School.

September 11, 2012

Walgreens on Monday announced that it has priced an underwritten public offering of senior notes.

DEERFIELD, Ill. — Walgreens on Monday announced that it has priced an underwritten public offering of senior notes, the net proceeds from which will be used to repay — in full — money that was borrowed to fund the cash consideration in its acquisition of a 45% stake in Alliance Boots and for general corporate purposes, including its previously announced USA Drug acquisition.

The senior notes consist of:

  • $550 million of floating rate notes due 2014;

  • $750 million of 1% notes due 2015;

September 6, 2012

Safeway will package $150 million in real healthcare savings into an overall wellness strategy to be implemented over the course of 2013, the grocer's chairman and CEO Steve Burd told analysts Thursday morning at the Goldman Sachs 19th Annual Global Retailing Conference.

NEW YORK — Safeway will package $150 million in real healthcare savings into an overall wellness strategy to be implemented over the course of 2013, the grocer's chairman and CEO Steve Burd told analysts Thursday morning at the Goldman Sachs 19th Annual Global Retailing Conference. 

March 14, 2012

Grocer A&P has emerged from bankruptcy as a privately held company.

MONTVALE, N.J. — Grocer A&P has emerged from bankruptcy as a privately held company.

As previously announced, Mount Kellett Capital Management, The Yucaipa Cos. and investment funds managed by Goldman Sachs Asset Management, have provided $490 million in debt and equity financing to sponsor A&P’s reorganization plan and complete its balance sheet restructuring. In addition, JP Morgan and Credit Suisse arranged a $645 million exit financing facility.

November 11, 2011

A former Goldman Sachs executive will join Valeant Pharmaceuticals as EVP and CFO.

MISSISSAUGA, Ontario — A former Goldman Sachs executive will join Valeant Pharmaceuticals as EVP and CFO.

Howard Schiller will take over the position from Philip Loberg, who has been serving as Valeant's interim CFO on Dec. 1. Prior to his new role, Schiller was COO for Goldman Sachs' investment banking division until his retirement in January.

July 15, 2011

Clorox on Friday confirmed it has received an unsolicited conditional proposal from Icahn Enterprises to acquire the company for $76.50 per share, subject to due diligence, financing and other conditions.

OAKLAND, Calif. — Clorox on Friday confirmed it has received an unsolicited conditional proposal from Icahn Enterprises to acquire the company for $76.50 per share, subject to due diligence, financing and other conditions. Clorox said its board of directors, in consultation with its financial and legal advisers, will review the proposal in due course. 

Goldman, Sachs & Co. and J.P. Morgan Securities are serving as financial advisers, and Wachtell, Lipton, Rosen & Katz is legal adviser.

April 1, 2011

GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

PITTSBURGH — GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

Of the shares offered, 16 million are being issued and sold by GNC and 6.5 million shares are being sold by selling stockholders.

In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3.4 million shares. That offering is expected to close on April 6.

July 22, 2010

Private equity firm Carlyle Group is reportedly looking to sell skin care company Philosophy for...